Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant

This report describes the behavioral and electrophysiological analysis of regulatable transgenic mice expressing mutant repeat domains of human Tau (TauRD). Mice were generated to express TauRD in two forms, differing in their propensity for β-structure and thus in their tendency for aggregation (“pro-aggregant” or “anti-aggregant”) (Mocanu et al., 2008). Only pro-aggregant mice show pronounced changes typical for Tau pathology in Alzheimer's disease (aggregation, missorting, hyperphosphorylation, synaptic and neuronal loss), indicating that the β-propensity and hence the ability to aggregate is a key factor in the disease. We now tested the mice with regard to neuromotor parameters, behavior, learning and memory, and synaptic plasticity and correlated this with histological and biochemical parameters in different stages of switching TauRD on or off. The mice are normal in neuromotor tests. However, pro-aggregant TauRD mice are strongly impaired in memory and show pronounced loss of long-term potentiation (LTP), suggesting that Tau aggregation specifically perturbs these brain functions. Remarkably, when the expression of human pro-aggregant TauRD is switched on for ∼10 months and off for ∼4 months, memory and LTP recover, whereas aggregates decrease moderately and change their composition from mixed human plus mouse Tau to mouse Tau only. Neuronal loss persists, but synapses are partially rescued. This argues that continuous presence of amyloidogenic pro-aggregant TauRD constitutes the main toxic insult for memory and LTP, rather than the aggregates as such.

[1]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[2]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Mandelkow,et al.  Domains of tau protein and interactions with microtubules. , 1994, Biochemistry.

[4]  W. Kamphorst,et al.  The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. , 2007, Journal of neuropathology and experimental neurology.

[5]  J. Kuret,et al.  Inhibition of Tau Polymerization with a Cyanine Dye in Two Distinct Model Systems* , 2009, The Journal of Biological Chemistry.

[6]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[7]  R. D'Hooge,et al.  Neurocognitive and Psychotiform Behavioral Alterations and Enhanced Hippocampal Long-Term Potentiation in Transgenic Mice Displaying Neuropathological Features of Human α-Mannosidosis , 2005, The Journal of Neuroscience.

[8]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[9]  Laura Petrosini,et al.  Automatic recognition of explorative strategies in the Morris water maze , 2003, Journal of Neuroscience Methods.

[10]  R. Nelson,et al.  Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.

[11]  Susumu Tonegawa,et al.  Transgenic Inhibition of Synaptic Transmission Reveals Role of CA3 Output in Hippocampal Learning , 2008, Science.

[12]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[13]  E. Mandelkow,et al.  Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.

[14]  Bin Zhang,et al.  Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy , 2004, The Journal of Neuroscience.

[15]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[16]  T. Hashikawa,et al.  Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[18]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[19]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[20]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[21]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[22]  C. Hoogenraad,et al.  Dynamic Microtubules Regulate Dendritic Spine Morphology and Synaptic Plasticity , 2009, Neuron.

[23]  Israel Hernandez,et al.  The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule , 2009, The Journal of Neuroscience.

[24]  Jonathan R. Whitlock,et al.  Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.

[25]  C Chen,et al.  Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. , 1997, Annual review of neuroscience.

[26]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[27]  E. Mandelkow,et al.  Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.

[28]  E. Mandelkow,et al.  Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.

[29]  W Zieglgänsberger,et al.  Precisely localized LTD in the neocortex revealed by infrared-guided laser stimulation. , 1999, Science.

[30]  M. Wilson,et al.  NMDA receptors, place cells and hippocampal spatial memory , 2004, Nature Reviews Neuroscience.

[31]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[32]  M. Albert,et al.  Perseveration in Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[33]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[34]  Dietmar Schmitz,et al.  Synaptic plasticity at hippocampal mossy fibre synapses , 2005, Nature Reviews Neuroscience.

[35]  Hermann Bujard,et al.  The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy* , 2007, Journal of Biological Chemistry.

[36]  S. Maeda,et al.  Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. , 2008, Current Alzheimer research.

[37]  K. Ashe,et al.  Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.

[38]  Frank Bradke,et al.  Control of neuronal polarity and plasticity--a renaissance for microtubules? , 2009, Trends in cell biology.

[39]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[40]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[41]  P. Davies,et al.  Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.

[42]  M. Goedert,et al.  Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.

[43]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[44]  D. Storm,et al.  Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning , 1998, Nature Neuroscience.

[45]  Boris Schmidt,et al.  Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. , 2007, Biochemistry.

[46]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[47]  F. LaFerla,et al.  Relevance of Transgenic Mouse Models to Human Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[48]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[49]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.

[50]  D. Manahan‐Vaughan,et al.  Frequency Facilitation at Mossy Fiber–CA3 Synapses of Freely Behaving Rats Is Regulated by Adenosine A1 Receptors , 2008, The Journal of Neuroscience.

[51]  Jason Eriksen,et al.  A decade of modeling Alzheimer's disease in transgenic mice. , 2006, Trends in genetics : TIG.

[52]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[53]  Jeff Kuret,et al.  Two motifs within the tau microtubule‐binding domain mediate its association with the hsc70 molecular chaperone , 2008, Journal of neuroscience research.

[54]  E. Mandelkow,et al.  Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.

[55]  Stuart C. Feinstein,et al.  Structural and Functional Differences between 3-Repeat and 4-Repeat Tau Isoforms , 2000, The Journal of Biological Chemistry.

[56]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[57]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[58]  S. Kügler,et al.  Alzheimer's disease: old problem, new views from transgenic and viral models. , 2010, Biochimica et biophysica acta.

[59]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[60]  G. Bloom,et al.  Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules , 1999, The Journal of Biological Chemistry.

[61]  E. Dent,et al.  Activity-Dependent Dynamic Microtubule Invasion of Dendritic Spines , 2008, The Journal of Neuroscience.

[62]  Michael Frotscher,et al.  Hippocampal Synapses Depend on Hippocampal Estrogen Synthesis , 2004, The Journal of Neuroscience.

[63]  H. Geerts,et al.  Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease , 1999, FEBS letters.

[64]  F Bertocchini,et al.  Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning , 1999, The EMBO journal.

[65]  N. Hirokawa,et al.  Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA , 1989, The Journal of cell biology.

[66]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[67]  Phillip B. Jones,et al.  In Vivo Imaging Reveals Dissociation between Caspase Activation and Acute Neuronal Death in Tangle-Bearing Neurons , 2008, The Journal of Neuroscience.

[68]  E. Mandelkow,et al.  Tau-based treatment strategies in neurodegenerative diseases , 2008, Neurotherapeutics.

[69]  K. Reymann,et al.  When Are Class I Metabotropic Glutamate Receptors Necessary for Long-Term Potentiation? , 1998, The Journal of Neuroscience.

[70]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[71]  T. Ben-Hur,et al.  A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics , 2008, Experimental Neurology.

[72]  R. J. McDonald,et al.  Hippocampus, amygdala, and memory deficits in rats , 1990, Behavioural Brain Research.

[73]  C. Chapman,et al.  Effects of GABAA inhibition on the expression of long‐term potentiation in CA1 pyramidal cells are dependent on tetanization parameters , 1998, Hippocampus.

[74]  Roger Anwyl,et al.  Synaptic plasticity in animal models of early Alzheimer's disease. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[75]  M. Hutton,et al.  Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain , 2004, Brain Research.

[76]  E. Mandelkow,et al.  The 'jaws' model of tau-microtubule interaction examined in CHO cells. , 1997, Journal of cell science.

[77]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[78]  R. Wade-Martins,et al.  Knock-out and transgenic mouse models of tauopathies , 2009, Neurobiology of Aging.

[79]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[80]  S. Feinstein,et al.  Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. , 2000, The Journal of biological chemistry.

[81]  K. Ashe,et al.  Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. , 2008, The American journal of pathology.

[82]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[83]  D. Rieu,et al.  Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia , 2005, Journal of the Neurological Sciences.

[84]  S. Feinstein,et al.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau , 1994, The Journal of cell biology.

[85]  Scott A. Small,et al.  Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis , 2008, Neuron.

[86]  E. Kandel The Molecular Biology of Memory Storage: A Dialogue Between Genes and Synapses , 2001, Science.

[87]  W. Kamphorst,et al.  The &Dgr;K280 Mutation in MAP tau Favors Exon 10 Skipping In Vivo , 2007 .

[88]  Koji Abe,et al.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. , 2005, The American journal of pathology.

[89]  William J Ray,et al.  Beyond amyloid: the next generation of Alzheimer's disease therapeutics. , 2007, Molecular interventions.

[90]  C. Léránth,et al.  Median raphe mediates estrogenic effects to the hippocampus in female rats , 2004, The European journal of neuroscience.

[91]  E. Mandelkow,et al.  Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.